News
of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 29 lots of 100 mg strength). This recall is due to the detection of an impurity – N-Nitroso-N-methyl-4 ...
Losartan tablets have been approved in 25-mg, 50-mg, and 100-mg doses, and losartan/hydrochlorothiazide combination tablets will be available in 50-mg/12.5-mg, 100-mg/12.5-mg, and 100-mg/25-mg ...
This covers lot No. JB8912 of Losartan Potassium Hydrochlorothiazide 100 mg or 25 mg tablets in 1,000-count bottles, expiration date 06/2020. None of the recalled tablets were distributed before ...
PISCATAWAY, N.J., Feb. 28, 2019 /PRNewswire/ -- Camber Pharmaceuticals, Inc. is recalling 87 lots of Losartan Tablets USP 25 mg, 50 mg, and 100 mg to consumer level. This recall was prompted due ...
Mint Pharmaceuticals Inc. is recalling all lots of its prescription losartan ... HCTZ 50/12.5 mg TABLETS Mint Pharmaceuticals Inc. 02389657 2005011156 June 2023 MINT-LOSARTAN/HCTZ 100/12.5 mg ...
Teva Canada is voluntarily recalling two lots of combination Losartan/hydrochlorothiazide (HCTZ) tablets ... 100/12.5 mg NL1422 10/2019 APO-LOSARTAN/HCTZ 02371251 100/25 mg NL1429 08/2019 APO ...
Antihypertensive efficacy and safety of losartan/hydrochlorothiazide (HCTZ) combinations have not been adequately studied in Asians. In this open-label, 12-week study in seven Asian areas ...
Macleods Pharmaceuticals is recalling 32 lots of losartan potassium USP tablets and losartan potassium/hydrochlorothiazide (HCTZ) combination tablets after discovering trace amounts of the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results